Physician profile
Timothy Guy Grube
NPI 1194720870
$260,374.99
in general payments reported to CMS, 2019-2025
33 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $12K · 2021: $34K · 2022: $62K · 2023: $34K · 2024: $34K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $88K · Food and Beverage: $6,246 · Travel and Lodging: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $88,000.00 |
| Food and Beverage | $6,245.69 |
| Travel and Lodging | $327.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $203,342.81 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $52,350.16 | 2019-2023 | |
| Medtronic, INC. | $1,645.23 | 2021-2023 | Interstim |
| Astellas Pharma US INC | $482.15 | 2019-2025 | Veozah |
| Axonics, INC. | $295.26 | 2022-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $269.17 | 2023-2025 | Gemtesa, Myfembree |
| Exeltis, USA INC. | $239.03 | 2021-2025 | Slynd |
| Pfizer INC. | $237.34 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $141.60 | 2021-2025 | |
| Myovant Sciences INC. | $120.94 | 2021-2022 | |
| Hologic Sales and Service, LLC | $120.34 | 2019-2024 | Acessa Provu System, Aptima |
| Therapeuticsmd, INC. | $117.77 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $101.56 | 2019-2020 | |
| Momentis Surgical INC. | $101.00 | 2022 | |
| Merck Sharp & Dohme LLC | $90.92 | 2019-2023 | Gardasil 9 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $89.19 | 2021-2022 | |
| Boston Scientific Corporation | $88.69 | 2019-2021 | |
| Organon LLC | $83.38 | 2021-2023 | Nexplanon |
| Amgen INC. | $77.12 | 2019-2024 | Prolia, Evenity |
| Bluewind Medical | $55.32 | 2024 | Revi |
| Millicent US INC | $48.59 | 2025 | Intrarosa, Femlyv |
| Radius Health, INC. | $42.05 | 2022-2024 | Tymlos |
| Allergan, INC. | $39.90 | 2019-2020 | |
| Coopersurgical, INC. | $31.77 | 2020-2024 | Paragard T 380a |
| Novo Nordisk INC | $31.09 | 2024-2025 | Wegovy |
| Ethicon US, LLC | $22.77 | 2019 | |
| Scynexis, INC. | $21.97 | 2022 | |
| Acella Pharmaceuticals, LLC | $21.39 | 2025 | NP Thyroid 60 |
| Olympus America INC. | $15.93 | 2025 | Olympus |
| Medtronic USA, INC. | $14.07 | 2020 | |
| Lupin INC. | $13.95 | 2019 | |
| Avion Pharmaceuticals | $11.47 | 2020 | |
| Minerva Surgical, INC | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Grube listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.